Key result
TCF7L2 T allele linked to ~2.3-fold higher odds of coronary lesions in non-diabetics.
Observational (n=1,448)
Answers are grounded in this paper and cite their sources.
Prospective analysis demonstrates increased coronary artery disease severity and mortality among non-diabetic TCF7L2 risk-allele carriers, indicating independent cardiovascular risks.
BACKGROUND: TCF7L2 polymorphisms have been consistently associated with type 2 diabetes mellitus in different populations and type 2 diabetes mellitus is a major risk factor for cardiovascular disease, especially coronary artery disease. This study aimed to evaluate the association between TCF7L2 polymorphism rs7903146 and coronary artery disease in diabetic and non-diabetic subjects. METHODS AND RESULTS: two populations were studied in order to assess severity of coronary artery disease and cardiovascular events incidence. Eight-hundred and eighty nine subjects who were referred for cardiac catheterization for coronary artery disease diagnosis were cross-sectionally evaluated for coronary lesions (atherosclerotic burden) and 559 subjects from the MASS-II Trial were prospectively followed-up for 5 years and assessed for major cardiovascular events incidence. As expected, rs7903146 T allele was associated with diabetes. Although diabetic patients had a higher prevalence of coronary lesions, no association between TCF7L2 genotype and coronary lesions was found in this subgroup. However, non-diabetic individuals carrying the T allele were associated with a significantly higher frequency of coronary lesions than non-diabetic non-carriers of the risk allele (adjusted OR = 2.32 95%CI 1.27-4.24, p = 0.006). Moreover, presence of multi-vessel coronary artery disease was also associated with the CT or TT genotypes in non-diabetics. Similarly, from the prospective sample analysis, non-diabetics carrying the CT/TT genotypes had significantly more composite cardiovascular end-points events than CC carriers (p = 0.049), mainly due to an increased incidence of death (p = 0.004). CONCLUSIONS: rs7903146 T allele is associated with diabetes and, in non-diabetic individuals, with a higher prevalence and severity of coronary artery disease and cardiovascular events. name of registry site (see list below), registration number, trial registration URL in brackets. CLINICAL TRIAL REGISTRATION INFORMATION: MEDICINE, ANGIOPLASTY, OR SURGERY STUDY (MASS II): Unique identifier: ISRCTN66068876.
No takes yet. Share an insight, caveat, or question.
Sousa et al. (2009) conducted an observational in Coronary artery disease (n=1,448). TCF7L2 rs7903146 T allele (CT or TT genotypes) vs. Non-carriers of the risk allele (CC genotype) was evaluated on Coronary lesions (atherosclerotic burden) and composite major cardiovascular events (OR 2.32, 95% CI 1.27-4.24, p=0.006). TCF7L2 rs7903146 T allele in non-diabetics was associated with higher frequency of coronary lesions and cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: